Enceladus Pharmaceuticals Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Enceladus Pharmaceuticals General Information

Description

Operator of a drug development company intended to aim at finding innovative combinations of existing drugs and drug carrier systems. The company's drugs contain an anti-inflammatory corticosteroid that selectively targets the drug to the actual sites of pathology in inflammatory disorders, enabling users to get liposomal formulations of corticosteroids to treat inflammatory, autoimmune diseases, and cancer.

Contact Information

Website
www.enceladus.nl
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Sumatrastraat 32
  • 1094 ND Naarden
  • Netherlands

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enceladus Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 22-Jun-2021 Completed Out of Business
3. Early Stage VC 09-Jul-2007 Completed Startup
2. Early Stage VC 01-Jan-2005 Completed Startup
1. Spin-Off 01-Jan-2005 Completed Startup
To view Enceladus Pharmaceuticals’s complete valuation and funding history, request access »

Enceladus Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug development company intended to aim at finding innovative combinations of existing drugs and drug car
Drug Discovery
Naarden, Netherlands
2 As of 2020
00000000 00

00000

r adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna al
0000 000000000
Seattle, WA
00 As of 0000
0000
0000000000 0 0000

000000

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occae
000000000000000
Noain, Spain
000 As of 0000
00.000
000000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enceladus Pharmaceuticals Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lumen Bioscience Venture Capital-Backed Seattle, WA 00 0000 0000000000 0 0000
00000000 000000000 Private Equity-Backed Noain, Spain 000 00.000 000000000000 00.000
000000 000000 0000 Corporate Backed or Acquired Toronto, Canada 000 000000&0
00000000 000000000 Private Equity-Backed Stockholm, Sweden 000 000.00 00000000000
000 00000000000000 Formerly PE-Backed Ramapo, NY 0000 00.000 0000000000.
You’re viewing 5 of 27 competitors. Get the full list »

Enceladus Pharmaceuticals Patents

  • 32

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Enceladus Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003256164-A1 Vesicle-encapsulated corticosteroids for the treatment of cancer Active 27-Aug-2002 000000000
AU-2003266322-A1 Lipid-polymer-conjugates compositions comprising corticosteroids for the treatment of cancer Inactive 27-Aug-2002 000000000
AU-2003258686-A1 Vesicle-encapsulated corticosteroids for the treatment of cancer Inactive 27-Aug-2002 000000000
AU-2003256164-B2 Vesicle-encapsulated corticosteroids for the treatment of cancer Inactive 27-Aug-2002 000000000
CA-2496763-C Vesicle-encapsulated corticosteroids for the treatment of cancer Inactive 27-Aug-2002 A61K9/127
To view Enceladus Pharmaceuticals’s complete patent history, request access »

Enceladus Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial